10.1097/JCMA.0000000000000389 27 ChenY.MushashiF.SonS.BhattiP.DummerT.MurphyR
In fact, an estimated 80 million Americans thats one in four people in the U.S
LMNA-related muscular dystrophy: Identification of variants in alternative genes and personalized clinical translation
Key takeaways Anxiety is not a common side effect of Wegovy, but some people may experience symptoms of anxiety due to the drugs other side effects, such as hypoglycemia or dehydration
McLaughlin breaks down who may qualify for GLP-1 therapy You may be a candidate if you have: BMI 30 (obesity), or BMI 27 with at least one weight-related condition (type 2 diabetes, hypertension, dyslipidemia, sleep apnea) Type 2 diabetes or prediabetes Insulin resistance or metabolic syndrome Cardiovascular risk factors where weight loss would improve outcomes GLP-1s are typically not approved for patients with: Personal or family history of medullary thyroid cancer or MEN2 Prior severe pancreatitis linked to GLP-1 use Significant untreated GI disorders or eating disorders Approval may also depend on insurance requirements, documented lifestyle attempts, and whether the prescription is for diabetes vs
I can hear it now - "I only pay $25 a month for my GLP-1 but my pharmacy says that they can't get it"